The U.S. pharmaceutical industry loses $188 billion annually due to medication non-adherence, according to a 2012 CapGemini report. This same report indicates that just a 10 percent increase in adherence rates would generate revenue of $41 billion in the U.S. alone and $124 billion globally.
Successful medication adherence is a complex task that involves the effort of a number of stakeholders — pharmaceutical companies, physicians, payers, and, of course, the patient — and they each want the same thing: positive health outcomes.
The 7th Patient Engagement, Education and Adherence Summit brings together leading industry innovators to connect with peers and discuss the latest trends and best practices in medication adherence, patient engagement, health literacy and partnering with patient advocacy groups.
This year’s event is all about enhanced patient education and engagement for improved health outcomes across all industry sectors. We’re packing the agenda with a full-day case study showcase, panel discussions, interactive sessions and roundtables led by top industry executives.
“The Patient Adherence and Advocacy Summit is one of the few places where industry can connect with other stakeholders in patient adherence and outcomes from a real-world, experiential perspective. This forum allows for the robust exchange of ideas and strategies that can have a positive impact on the patients we all serve.”
—Lisa Valtierra, Associate Director, Cross-Cultural Marketing, BOEHRINGER INGELHEIM
“Inspirational speakers. I really learned a lot.”
—Director, Life Cycle Management, ALKERMES, INC.
—Senior Director, LEXICON PHARMACEUTICALS
—Director, Marketing, BOEHRINGER INGELHEIM
—Principal, IMS HEALTH
This conference is designed for life science professionals (from pharma, biotech and medical device companies, as well as physicians and payers) with responsibilities in the following areas:
Advocacy groups and patient advocates who work toward the benefit of the patient in conjunction with pharmaceutical companies, and who connect with ePatients, should also consider attending.
Additionally, this conference is of interest to: